arrow
C

Chun-Wei Chen

city of hope comprehensive cancer center
H指数:41
被引数:8,704

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FANCM is required for the PAX3::FOXO1-driven oncogenic program in rhabdomyosarcoma

FANCM在横纹肌肉瘤中对于PAX3::FOXO1驱动的癌基因程序是必需的

2026-09-010
OAAI
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics

抑制ADSS2-mediated从头合成AMP使急性髓系白血病对BH3模拟物重新敏感

2026-06-260
PRE
Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia

靶向METTL1/m7G轴作为髓系白血病的治疗策略

Blood
IF23.1
2025-12-010
PRE
Disparate leukemia mutations converge on nuclear phase-separated condensates

异质性白血病突变汇聚于细胞核相分离凝聚体

Cell
IF42.5
2025-11-040
OA
Synergistic Efficacy of Dual Menin and PRMT5 Targeting Against NPM1 mutated and KMT2A- rearranged Leukemia

双Menin和PRMT5靶向治疗NPM1突变型和KMT2A重排型白血病的协同疗效

BLOOD
IF23.1
2024-11-050
PRE
Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery
2024-02-232
OAAI
A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens
2024-02-055
OAAI
METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation
2024-02-0113
OAAI
SRCAP mutations drive clonal hematopoiesis through epigenetic and DNA repair dysregulation (vol 30, pg 1503, 2023)
2024-02-010
OA
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG
2023-09-212
OAAI
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
2023-09-205
OA